Judit Kállai

Most-cited papers

1. Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods

   R. Gindele, Krisztina Pénzes-Daku, G. Balogh, Judit Kállai +5 more

   2021Biomolecules17 citations Open access

   Semantic Scholar

   Save

2. Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients

   L. Balogh, É. Katona, Z. Mezei, Judit Kállai +5 more

   2018Molecular and Cellular Biochemistry16 citations Open access

   Semantic Scholar

   Save

3. Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.

   Z. Mezei, É. Katona, Judit Kállai, Z. Bereczky +6 more

   2017Thrombosis Research13 citations

   Semantic Scholar

   Save

4. Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.

   Z. Mezei, É. Katona, Judit Kállai, Z. Bereczky +6 more

   2016Thrombosis Research12 citations Open access

   Semantic Scholar

   Save

5. Novel STAT‐3 gain‐of‐function variant with hypogammaglobulinemia and recurrent infection phenotype

   Melinda Erdős, M. Tsumura, Judit Kállai, Á. Lányi +4 more

   2021Clinical and Experimental Immunology11 citations Open access

   Semantic Scholar

   Save

6. Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.

   Barbara Baráth, Réka Bogáti, Tünde Miklós, Judit Kállai +4 more

   2021Thrombosis Research11 citations

   Semantic Scholar

   Save

7. Deficiencies of the Natural Anticoagulants – Novel Clinical Laboratory Aspects of Thrombophilia Testing

   Z. Bereczky, R. Gindele, M. Speker, Judit Kállai

   2016EJIFCC11 citations

   Semantic Scholar

   Save

8. The Voltage-Gated Hv1 H+ Channel Is Expressed in Tumor-Infiltrating Myeloid-Derived Suppressor Cells

   Marco Cozzolino, Adrienn Gyöngyösi, É. Korpos, P. Gogolák +4 more

   2023International Journal of Molecular Sciences9 citations Open access

   Semantic Scholar

   Save

9. 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel

   T. Szanto, Á. Fehér, É. Korpos, Adrienn Gyöngyösi +6 more

   2023Pharmaceuticals9 citations Open access

   Semantic Scholar

   Save

10. Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors

    K. Szegedi, Z. Szabó, Judit Kállai, J. Király +8 more

    2023Journal of Clinical Medicine7 citations Open access

    Semantic Scholar

    Save

11. A novel mutation in SLC39A7 identified in a patient with autosomal recessive agammaglobulinemia: The impact of the J Project

    Melinda Erdős, K. Mironska, L. Kareva, K. Stavric +4 more

    2022Pediatric Allergy and Immunology7 citations Open access

    Semantic Scholar

    Save

12. Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing

    R. Gindele, A. Kerényi, Judit Kállai, G. Pfliegler +8 more

    2021Life7 citations Open access

    Semantic Scholar

    Save

13. Topically applied N,N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release.

    G. Béke, A. Lendvai, E. Hollósi, N. Braun +9 more

    2024Journal of Investigative Dermatology5 citations Open access

    Semantic Scholar

    Save

14. 76 N,N-Dimethylglycine Sodium Salt as a Multifaceted Skin Agent Targeting Skin Inflammation, Microvascular Biology, and Senescence-Driven Hair Loss

    A. Lendvai, G. Béke, E. Hollósi, N. Braun +9 more

    2025Journal of Investigative Dermatology0 citations

    Semantic Scholar

    Save

15. Identification of a new family of inhibitors of the human Hv1 proton channel.

    Á. Fehér, Eva Korpos-Pintye-Gyuri, Martina Piga, T. Tomašič +7 more

    2023Biophysical Journal0 citations

    Semantic Scholar

    Save